RE:RE:HEXO MD&A - 2022 Q1 (Today, Dec 14, 2021)Read the MD&A and get the complete pixcture to include:
1. Chair Board replaced.
2. CFO replaced - 5th CEO in 3 years.
3. International Sales down.
4. Beverage sales down.
5. Long term debt - $525 Million
6. Shares today - 344 Million and could rise to 729 Million.
7. HEXO dales less REDECAN and ZENABIS has not grown.
8. Going concern - how to pay holders of the proomnissary note
9. Read the MD&A and get smart.
You will not hear any of the above in a news release, or from those on this site who wanted you to buy this stock over the past 6-8 months.
DYODD
1.